• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

良性和恶性胃部病变中的肠化生

Intestinal metaplasia in benign and malignant gastric lesions.

作者信息

Kini U, Nirmala V, Thomas J A

机构信息

Department of Pathology, St. John's Medical College, Bangalore, India.

出版信息

Indian J Pathol Microbiol. 1990 Apr;33(2):137-43.

PMID:2391144
Abstract

The purpose of this study has been to determine the prevalence of intestinal metaplasia (IM) and its subtypes in normal, benign and malignant states, with special reference to the significance of presence as well as location of sulphomucins in the metaplastic epithelium. Sixty-seven specimens of the normal, benign chronic gastric disease and gastric carcinoma have been studied. The overall prevalence of IM in gastric carcinoma has been found to be much higher (67 percent) than in the normal (nil) and benign lesions of stomach (11 percent). The sulphomucins producing IM also has a higher prevalence in gastric carcinoma (70 percent) but can occur in benign conditions also (40 percent). On the other hand Type III IM, characterized by sulphomucins in the columnar cells is seen only in gastric carcinoma, and not in the benign lesions.

摘要

本研究的目的是确定肠化生(IM)及其亚型在正常、良性和恶性状态下的患病率,特别提及化生上皮中硫黏液素的存在及位置的意义。已对67份正常、良性慢性胃病和胃癌标本进行了研究。已发现胃癌中IM的总体患病率(67%)远高于正常胃(无)和胃良性病变(11%)。产生硫黏液素的IM在胃癌中的患病率也较高(70%),但在良性情况下也可出现(40%)。另一方面,以柱状细胞中存在硫黏液素为特征的III型IM仅见于胃癌,而不见于良性病变。

相似文献

1
Intestinal metaplasia in benign and malignant gastric lesions.良性和恶性胃部病变中的肠化生
Indian J Pathol Microbiol. 1990 Apr;33(2):137-43.
2
Intestinal metaplasia of the gastric mucosa: a study of its incidence in various disease states.
Riv Eur Sci Med Farmacol. 1991 Feb-Apr;13(1-2):25-8.
3
Intestinal metaplasia and gastric carcinoma. A histochemical and immunohistochemical study.肠化生与胃癌。一项组织化学和免疫组织化学研究。
Chin Med J (Engl). 1990 Oct;103(10):821-5.
4
Subtypes of intestinal metaplasia and their relationship to Helicobacter pylori.肠化生的亚型及其与幽门螺杆菌的关系。
J Environ Pathol Toxicol Oncol. 1996;15(2-4):221-4.
5
[Intestinal metaplasia of the gastric mucosa and its relation with gastric carcinoma].
G E N. 1994 Jul-Sep;48(3):190-4.
6
Intestinal metaplasia--its association with gastric cancer.肠化生——其与胃癌的关联。
Trop Gastroenterol. 1995 Oct-Dec;16(4):22-6.
7
bcl-2 protein expression in gastric remnant mucosa and gastric cancer 15 or more years after partial gastrectomy.胃部分切除术后15年及更长时间胃残余黏膜和胃癌中bcl-2蛋白的表达
Mod Pathol. 1997 Oct;10(10):1021-7.
8
Minute gastric carcinoma of differentiated type with special reference to the significance of intestinal metaplasia, proliferative zone, and p53 protein during tumor development.分化型微小胃癌,特别关注肿瘤发生过程中肠化生、增殖带和p53蛋白的意义。
Cancer. 1999 Apr 15;85(8):1719-29.
9
Histogenesis of intestinal and diffuse types of gastric carcinoma.肠型和弥漫型胃癌的组织发生
Scand J Gastroenterol Suppl. 1991;180:160-4.
10
Extended intestinal metaplasia. A survey of 1392 gastrectomies from dwellers of the Pacific basin.
Anticancer Res. 2004 Sep-Oct;24(5B):3185-92.

引用本文的文献

1
Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence.肠上皮化生亚型作为胃癌风险标志物的效用。证据综述。
Int J Cancer. 2013 Sep 1;133(5):1023-32. doi: 10.1002/ijc.28003. Epub 2013 Feb 5.